{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-Gram Negative Ertapenem",
        "VITEK\u00ae 2 AST-GN Ertapenem"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K152075",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121546"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "February 29, 2016",
    "Summary Letter Received Date": "March 1, 2016",
    "Submission Date": "July 24, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ertapenem"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Gram negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) microdilution"
    ],
    "Methodologies": [
        "Quantitative susceptibility testing",
        "Doubling dilution technique",
        "Microdilution methodology"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 AST-Gram Negative Ertapenem card for automated antimicrobial susceptibility testing using VITEK\u00ae 2 platforms",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of Gram negative bacilli as a laboratory aid in determining in vitro susceptibility to ertapenem, for use with VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems.",
    "fda_folder": "Microbiology"
}